population during the year 2003 (95% CI: 3.6-6.7). Dilated cardiomyopathy was most prevalent (75.8%) in all age groups, and the incidence increased remarkably with age. Lower prevalence of hypertrophic cardiomyopathy (13.6%) and left ventricle noncompaction cardiomyopathy (6.1%) was found. In children below 15 years of age, the incidence rate for all types of cardiomyopathies was 2.7/100,000 population. The overall mortality rate was 5.3%. Conclusion: Most cases of cardiomyopathy were identifi ed at an early age: below 15 years and above 35 years of age. Introducing preventive and early diagnosis programs may have an impact on reducing the mortality and morbidity from idiopathic cardiomyopathy.
population-based studies, examining the prevalence and causes of CHF in young patients in Qatar. This information is needed in order to develop strategic planning for prevention and treatment of this rising epidemic. The prevalence of the various types of cardiomyopathies may be different from those reported elsewhere and this may warrant specifi c strategic planning [3, 4] . Furthermore, the Qatari population, like other Arabian Gulf countries, has consanguineous family structure that is different from most of the world population.
In Qatar, the consanguinity rate is very high. Therefore, the population is in principle genetically homogenous [5] . This will serve as an ideal population for studying the genetics of cardiomyopathies with respect to the nature of the genetic polymorphism that can infl uence the power and interpretation of epidemiological data when dealing with more out-bred and heterogeneous populations. This study examined the rates of cardiomyopathies in the population below 50 years of age in Qatar, in the 1996-2003 period.
Subjects and Methods
We analyzed the data with respect to all patients below 50 years of age who were hospitalized with idiopathic cardiomyopathy during the 1996-2003 period. This study was based at Hamad General Hospital, Doha, which is the main tertiary care center in the country. Hence it was an ideal site for population-based studies. All patients with various types of cardiomyopathy were treated at this hospital. In the present study, the subjects were recruited from the Department Cardiology. The data were collected retrospectively from the medical records of the patients during the 1996-2002 period when they visited outpatient clinics for follow-up, and for the year 2003 it were prospective data from the clinical records at the time of patient's hospital discharge. Cases of cardiomyopathy were classifi ed according to World Health Organization/International Society and Federation of Cardiology task force on Cardiomyopathies [6, 7] . The inclusion criteria were subjects aged below 50 years and all nationalities in Qatar presenting with any type of cardiomyopathy. Those suffering from end-stage rheumatic valvular heart disease and CHF complicating acute myocardial infarction were excluded.
The studied subjects had complications of shortness of breath, arrhythmias, easy fatigability, chest pain, thromboembolic manifestations or congestive gastroentropathy symptoms and echocardiographic features of cardiomyopathy. The diagnosis of dilated cardiomyopathy (DCM) was essentially one of exclusion and was based on clinical symptoms, electrocardographic and chest roentgenographic fi ndings of ventricular dysfunction, supported by echocardiographic or angiographic confi rmation of global ventricular dilatation: left ventricular end diastolic volume more than or equal to 110 cm 3 /m 2 , left ventricular end systolic volume more than or equal to 44 cm 3 /m 2 , and left ventricular ejection fraction more than or equal to 50%. The diagnosis of hypertrophic cardiomyopathy (HCM) was based on specifi c echocardiographic criteria [8] . Echocardiographic measurements for HCM included left ventricular septal wall thickness, typically 1 15 mm, dilated left atrium ( 1 4 cm) and left ventricular enddiastolic diameter ! 45 mm. Normally, for the athletic heart, the septum is ! 15 mm, the left atrium is ! 4 cm and left ventricular end-diastolic diameter 1 45 mm.
Restrictive cardiomyopathy (RCM), in which endomyocardial scarring may affect one or both ventricles restricting ventricular fi lling was based on echocardiographic fi ndings, and/or the hemodynamic changes during ventriculography are diagnostic [9] . Peripartum cardiomyopathy was defi ned as CHF that occurs late in pregnancy or during the early postpartum period (the last trimester or up to 3 months postpartum) in the absence of congenital, coronary, or valvular heart disease or another recognized cause of heart failure. Patients were described to have unclassifi ed cardiomyopathy when they did not fi t readily into any group defi ned above.
Diagnosis of isolated ventricular noncompaction was based on the strict criteria of echocardiography. The criteria were an absence of signifi cant heart lesions; segmental thickening of the left ventricular myocardial wall consisting of two layers consisting of a thin, compacted epicardial and an extremely thickened endocardial layer with prominent trabeculations and deep recesses [10] .
We reviewed the clinical data of patients hospitalized with cardiomyopathy which included sociodemographic characteristics, symptoms, smoking habits, history of maternal gestational DM (DCM), medication, clinical examination, laboratory tests, chest X-ray, electrocardiogram, echocardiogram, stress test and/or cardiac catheterization (if available), as well as cardiac and/or skeletal biopsy (if needed).
Data are expressed as mean and standard deviation unless otherwise stated. Student's t test was used to ascertain the signifi cance of differences between mean values of two continuous variables.
Fisher exact test and 2 tests were performed to test for differences in proportions of categorical variables between two or more groups. The level p ! 0.05 was taken as the cut-off value for signifi cance.
Results
During the 8-year study period, 132 patients were diagnosed with idiopathic cardiomyopathy. Of these, 31.8% were Qataris and 68.2% non-Qataris. Of the Qatari patients, 33.3% married fi rst degree relatives and 23.8% second degree relatives, giving a high level of consanguineous marriages.
The sociodemographic features and clinical characteristics of all types of cardiomyopathy by nationality during the study period are shown in table 1 . The proportion of males (67.4%) was double that of females (32.6%). A majority of the adult cases were above 35 years of age. On average, in children below 15 years of age, the incidence rate of all types of cardiomyopathies was 2.9/100,000 population. For all types of cardiomy-opathies, DCM rate was the highest (75.8%), followed by HCM (13.6%) and left ventricle noncompaction cardiomyopathy (6.1%). RCM and ARVC (arrhythmogenic right ventricular cardiomyopathy) were the least (0.8%). The most common presentations for cardiomyopathies were shortness of breath (57.6%), palpitations (18.2%), chest pain (15.2%) and easy fatigability (12.9%). Abdominal pain was the main symptom in 4.6% of the cases, while stroke was an early manifestation in 2.3% of cases. Twenty-seven percent of the patients were smokers.
All types of cardiomyopathies by age group are presented in table 2 . DCM was the most prevalent cardiomyopathy in all age groups and the incidence increased remarkably with age. Hypertropic cardiomyopathy had two peaks; one below 15 years of age and the other in the 36-50 years age group. Nearly half (48.6%) of the children had DCM, 28.6% HCM and 20% left ventricular noncompaction cardiomyopathy.
From 1996 to 2002, the rate of all types of cardiomyopathies remained at 2.5/100,000 population per year (95% CI: 1.4-3.5), but it increased to 5.2/100,000 population in 2003 (95% CI: 3.6-6.7). Also, the prevalence rate of DCM was 17.5/100,000 population, which was much higher than HCM (3.1/100,000 population). Prevalence rates were greater for men, with a male:female ratio of 2: 1 for both DCM and HCM. The percentage of deaths due to cardiomyopathy was 5.3%, and all these were in the 16-35 years age group ( table 2 ) . Four deaths occurred in cases with DCM and one in RCM. DCM due to thalassemia was associated with the shortest period between diagnosis and death (2 years).
A rare association between cardiomyopathies and certain diseases is shown in table 3 . Among those cases, antiphospholipid syndrome and scleroderma have not been reported before. 
Discussion
There is no previous report describing the epidemiology of idiopathic cardiomyopathy in Qatar. In the 10-year period between 1991 and 2001, 2,342 patients were hospitalized with CHF. Of these, 53% were Qatari with CHF and hypertension [1] . The high consanguinity rate (46%) in Qatar made us register the incidence of idiopathic cardiomyopathy. We had previously reported striking patterns of cardiomyopathy in two Qatari families [1, 2, 4] .
Depending on the diagnostic criteria, the reported annual incidence of idiopathic DCM varied between 5 and 8 cases per 100,000 population [4, [11] [12] [13] . In our study, the overall prevalence of all types of cardiomyopathy was 2.5/100,000 population per year during the 1996-2002 period, and it doubled to 5.2/100,000 population in the year 2003. This could be explained in part by our greater awareness of such issue and also because, for this year, it was a prospective study. During the study period between 1996 and 2003, the prevalence of DCM and HCM were 17.5 and 3.1 per 100,000 population, respectively. However, the true incidence is probably underestimated, since many asymptomatic cases remain undetected. The ageadjusted prevalence of idiopathic DCM in the United States averages to 36 cases per 100,000 population [14] . In Japan, a nationwide epidemiological survey to estimate the total number of patients with idiopathic cardiomyopathy and the prevalence of the disorder revealed that crude prevalence per 100,000 population was estimated to be 14.0 for DCM, 17.3 for HCM and 0.2 for RVM [15] . The true natural history of idiopathic DCM is diffi cult to determine, since asymptomatic cardiomegaly may be present for months or years before being detected. Survival data from tertiary referral centers are similar, with a mortality rate ranging between 25 and 30% in 1 year and approximately 50% in 5 years [16] [17] [18] . The overall mortality rate in our study was 5.3%.
Most of the patients with cardiomyopathy are usually fi rst seen between the ages of 20 and 50 years, but the disorder may also affect the children and the elderly [17, 18] . The most common initial manifestation is heart failure, which occurs in 75-85% of patients. In most cases initial symptoms include dyspnea on exertion (86%), palpitations (30%) and peripheral edema (29%). Asymptomatic cardiomegaly is detected in 4-13% of patients. Abdominal pain is not an uncommon presentation either. Chest pain on exertion occurs as an initial symptom in 8-20% of patients [18] [19] [20] , and eventually occurs in approximately 35%. Systemic and pulmonary emboli are the initial manifestations in 1.5-4% of cases. Although atrial fi brillation is more common among patients with embolic events, it is present in fewer than 25% of such patients. Ventricular arrhythmias are common, but syncope and sudden death are rarely the initial presentation of the condition [15] [16] [17] [18] . In our study, the more frequent symptoms of cardiomyopathy were SOB (57.6%), palpitation (18.2%), chest pain (15.2%) and easy fatigue (12.9%) .
Ideally, all patients with DCM should be shown to be free of coronary artery disease (CAD); however, in practice, coronary angiography is not routinely performed in all cases with CHF. Thus, retrospective studies cannot control the conditions under which patients are recruited or investigated. It follows that most epidemiologic studies of DCM have compromised on the completeness of data on CAD in their subjects. In an Icelandic study, 75% of patients were shown to have normal coronary circulation [21] . In studies at Mayo Clinic, the incidence of normal coronary circulation for DCM was 58 and 47%, respectively [14] . In our study, we excluded cardiomyopathies complicating myocardial infarction, and only 7 cases were documented to have CAD, confi rmed by angiography. The true incidence of pediatric cardiomyopathy is also unclear. In comparison with the annual incidence of cardiomyopathy in children in a North American (1.3/100,000), a Finnish (0.74/100,000) and an Australian study (1.24/100,000) [21] [22] [23] [24] [25] [26] , our study showed a higher rate (2.6/100,000) for the 8-year period. This higher incidence in our study might be related to the high consanguinity rate in Qatar (46%). Left ventricle noncompaction cardiomyopathy constituted 6.1% of all cardiomyopathies and 20% of pediatric and 0.97% of adult cardiomyopathies in Qatar. Worldwide, the incidence of left ventricular noncompaction cardiomyopathy is 0.05-0.24% in adults [25, 27] . Table 4 summarizes some of the reported studies for cardiomyopathy.
Study Limitations
The retrospective part of the study has some limitations. Coronary angiography was not available for a majority of the cases. The diagnosis of RCM was based only on echocardiographic fi ndings. However, cardiac catheterization is essential to confi rm the diagnosis of RCM. Genetic analysis was not performed. 
Conclusion
This study revealed that the incidence of idiopathic cardiomyopathy was high in children below 15 years and in adults above 35 years. Introducing preventive and early diagnostic programs may have an impact on reducing the mortality and morbidity rates of idiopathic cardiomyopathy. Routine baseline echocardiographic study and genetic analysis are recommended in families with consanguineous marriages and a history of idiopathic cardiomyopathy.
